{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bronchial+Disease&page=41", "query": { "condition": "Bronchial Disease", "page": 41 }, "page_size": 10 }, "pagination": { "page": 41, "page_size": 10, "total_count": 5779, "total_pages": 578, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bronchial+Disease&page=42&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bronchial+Disease&page=40&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T17:23:42.740Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02340676", "title": "A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Graft-versus-host-disease" ], "interventions": [ { "name": "Extracorporeal Photopheresis (ECP)", "type": "PROCEDURE" }, { "name": "Interleukin-2", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2015-02", "completion_date": "2025-09", "has_results": true, "last_update_posted_date": "2026-02-20", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02340676" }, { "nct_id": "NCT00634608", "title": "Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Allergic Rhinitis", "Asthma", "Back Pain", "Benign Prostatic Hypertrophy", "Bursitis", "Depression", "Anxiety", "Diabetes Mellitus", "Esophageal Reflux", "HIV Infections", "Hyperlipidemia", "Hypertension", "Insomnia", "Irritable Bowel Syndrome", "Obesity", "Osteoporosis (Senile)", "Shoulder Pain", "Sinusitis", "Symptomatic Menopause", "Urinary Incontinence", "Urinary Tract Infection", "Vaginitis" ], "interventions": [ { "name": "Health Information Prescription", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 224, "start_date": "2008-02", "completion_date": "2009-09", "has_results": false, "last_update_posted_date": "2016-09-30", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00634608" }, { "nct_id": "NCT07388524", "title": "Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lung Non-Small Cell Carcinoma" ], "interventions": [ { "name": "Atezolizumab", "type": "BIOLOGICAL" }, { "name": "Atezolizumab and Recombinant Human Hyaluronidase", "type": "BIOLOGICAL" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Patient Observation", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 336, "start_date": "2027-03-02", "completion_date": "2032-09-30", "has_results": false, "last_update_posted_date": "2026-10-28", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 119, "location_summary": "Beverly Hills, California • Los Angeles, California • Tarzana, California + 99 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Tarzana", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Millville", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT07388524" }, { "nct_id": "NCT02153359", "title": "Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "High Efficiency Particulate Air Cleaner", "type": "DEVICE" }, { "name": "Sham air cleaner", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 23, "start_date": "2014-02", "completion_date": "2018-09-11", "has_results": true, "last_update_posted_date": "2019-09-12", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 2, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02153359" }, { "nct_id": "NCT00124280", "title": "Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-small-cell Lung Carcinoma" ], "interventions": [ { "name": "RAD001", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 85, "start_date": "2005-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2016-11-18", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 2, "location_summary": "Las Vegas, Nevada • Houston, Texas", "locations": [ { "city": "Las Vegas", "state": "Nevada" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00124280" }, { "nct_id": "NCT06981078", "title": "A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Verekitug", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Upstream Bio Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 666, "start_date": "2025-07-02", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 29, "location_summary": "Bakersfield, California • Encino, California • Lomita, California + 23 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "Pomona", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06981078" }, { "nct_id": "NCT01446315", "title": "Assessing Decision Maker Tools for Asthma: the Asthma APGAR", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Use of Asthma APGAR system and tools", "type": "BEHAVIORAL" }, { "name": "Asthma APGAR tools", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Olmsted Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "5 Years to 60 Years" }, "enrollment_count": 1500, "start_date": "2011-10", "completion_date": "2014-10", "has_results": false, "last_update_posted_date": "2011-10-05", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01446315" }, { "nct_id": "NCT05224076", "title": "Home Air Quality Impact for Adults With Asthma", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma", "Environmental Exposure", "Home Environment Related Disease" ], "interventions": [ { "name": "Home Air Quality", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2022-03-30", "completion_date": "2024-02-28", "has_results": true, "last_update_posted_date": "2025-07-29", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05224076" }, { "nct_id": "NCT00971191", "title": "A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-Small Cell Lung Cancer (NSCLC)" ], "interventions": [ { "name": "PF-00299804", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2010-02", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2012-06-22", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Los Angeles, California", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00971191" }, { "nct_id": "NCT05631574", "title": "Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non Small Cell Lung Cancer", "Pancreatic Cancer", "Colorectal Cancer", "NSCLC", "PDAC", "CRC", "Relapsed Cancer", "Refractory Cancer", "Stage III Pancreatic Cancer", "Stage IV Pancreatic Cancer", "Stage III Non-small Cell Lung Cancer", "Stage IV Non-small Cell Lung Cancer", "Stage III Colorectal Cancer", "Stage IV Colorectal Cancer", "Stage III NSCLC", "Stage IV NSCLC", "KRAS Mutation-Related Tumors" ], "interventions": [ { "name": "BMF-219", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biomea Fusion Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2023-01-12", "completion_date": "2025-01-15", "has_results": false, "last_update_posted_date": "2025-02-07", "last_synced_at": "2026-10-28T17:23:42.740Z", "location_count": 19, "location_summary": "Goodyear, Arizona • Encinitas, California • La Jolla, California + 15 more", "locations": [ { "city": "Goodyear", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Miami Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05631574" } ] }